-
Influence of NICE Real-World Evidence Framework on HTA Submissions: Sensitivity Analyses in Real-World External Control Arm Studies
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis: A Case Study of Obesity
Sep 9, 2025, 16:22 PM -
Optimizing Pricing Models for Weight-Based and Multistock-Keeping Unit (SKU) Therapies in the EU4
Sep 9, 2025, 16:22 PM -
Subsequent Treatments and NICE Appraisals for DLBCL: A Review of Committee Discussions
Sep 9, 2025, 16:22 PM -
Healthcare and Economic Impact of Friedreich's Ataxia in Italy: A Stratified Analysis Based On Patients’ Ambulatory Status
Sep 9, 2025, 16:22 PM -
External Reference Pricing (ERP) Availability vs. Reimbursement Timelines in Poland and Other European Countries: The Analysis of EURIPID Database
Sep 9, 2025, 16:22 PM -
The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
Development of a Content-Valid Patient-Reported Outcome (PRO) Measure for Adults With Glycogen Storage Disease Type 1a (GSD1a): The GSD1a Symptom Diary-Adult Version
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis Of Migalastat Incorporation vs. Enzyme Replacement Therapies For Fabry Disease: Validation of a Cost-Assessment Tool In Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection
Sep 9, 2025, 16:22 PM -
Early Economic Modeling of Mutant TNF (mutTNF) As a BBB-Permeabilizing Adjunct in Breast Cancer Brain Metastases: A UK NHS Perspective
Sep 9, 2025, 16:22 PM -
Comparing ROBINS-I V2 and Downs Black for nRCTs in the Context of HTA
Sep 9, 2025, 16:22 PM -
Disparities in Access to Gene Therapy in the European Union: Ethical and Regulatory Challenges
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Bladder Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Are We There Yet? Mapping Member State Readiness for Local Implementation of the EU Health Technology Assessment (HTA) Regulation
Sep 9, 2025, 16:22 PM -
Unveiling the Economic Landscape: Burden of HR/HER2 Locally Recurrent Inoperable or Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Synthetic Data Generation Methods Using Artificial Intelligence (AI): A Simple New AI Tool That Generates Synthetic Data Using Generative Adversarial Network (CTGAN), Copula GANs, and Sequential Decision Tree Methods
Sep 9, 2025, 16:22 PM -
Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Personalized Lifestyle Interventions in Obesity/Overweight: A Systematic Review
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Sep 9, 2025, 16:22 PM
